Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Dicerna Pharmaceuticals, Inc."
Count: 17
Selected: 0
| NCT ID | Title |
|---|
| NCT05001269 | Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function | ||
| NCT04580420 | Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD | ||
| NCT05993416 | Treatment of Primary Hyperoxaluria Type 1 With Nedosiran | ||
| NCT04542590 | Natural History of Patients With PH3 and a History of Stone Events | ||
| NCT04042402 | Long Term Extension Study in Patients With Primary Hyperoxaluria | ||
| NCT05845398 | Phase 1b Study of DCR-AUD in Healthy Volunteers | ||
| NCT04764448 | A Study of Belcesiran in Patients With AATLD | ||
| NCT05021640 | Study of DCR-AUD in Healthy Volunteers | ||
| NCT03772249 | Study of Safety and Tolerability of DCR HBVS | ||
| NCT04174118 | Study of DCR-A1AT in Healthy Adult Volunteers | ||
| NCT05146882 | An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD) | ||
| NCT03847909 | A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 | ||
| NCT04555486 | Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients | ||
| NCT03392896 | Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria | ||
| NCT02795325 | A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1) | ||
| NCT02314052 | Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma | ||
| NCT02110563 | Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma |
